Michael Levy, senior vice president, Digital & Innovation, USP, explains the digital supply chain in a preview of his upcoming CPHI Milan panel presentation, The Next Phase of Pharma Supply Chains.
|Articles|April 2, 2017
- Pharmaceutical Technology-04-02-2017
- Volume 41
- Issue 4
Multi-Functional Mixing System for Pastes, Creams, and Gels
The VersaMix Multi-Shaft Mixer, from Ross, Charles & Son, is used to mix pastes, creams, and gel-type products.
The VersaMix Multi-Shaft Mixer, from Ross, Charles & Son, is used to mix pastes, creams, and gel-type products, with capabilities including powder dispersion, emulsification, dissolution, deagglomeration, homogenization, heating/cooling, and deaeration. All these functions are achieved in a closed system, without any transfer steps. The 10-gallon Ross VersaMix Model VMC-10 rated for 29.5 in Hg vacuum up to 15 psi internal pressure. The mixers three-wing anchor (3HP), high speed disperser (3HP), and high shear rotor/stator (3HP) operate independently at different speed ranges to deliver uniformity in low to high viscosity conditions up to several hundred thousand centipoise. All product contact surfaces are stainless steel type 316L polished to 180 grit finish. The mixer cover includes multiple ports for charging raw materials and installation of a vacuum/pressure transmitter, thermoprobe, and tank light. It mates with a jacketed cone-bottom vessel that is designed for 100% discharge through a flush diaphragm valve. A 23-in clearance from the valve outlet to the floor allows operators to position a bucket under the vessel to catch finished product after the mixing cycle.
Articles in this issue
over 9 years ago
EU–US Mutual Recognition Agreement on GMP Inspectionsover 9 years ago
Evaluating Progress in Analytical Quality by Designover 9 years ago
Staffing for China’s Rapidly Growing Biomanufacturing Industryover 9 years ago
Making the Most of Internal Auditsover 9 years ago
FDA Quality Metrics Initiative Challenges Manufacturersover 9 years ago
Nanoparticle Deagglomeration Technologyover 9 years ago
Mass Spectrometry System Standardizes WorkflowsRelated to this article
FDA approves tavapadon, first D1/D5 agonist, validating AbbVie's $8.7B Cerevel deal and an October five-strength oral tablet launch.
Richard Jaenisch weighs how FDA's new NAM rule could reshape preclinical testing and what CMC teams should do now, on Manufacturing Intelligence.
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
Merck licenses SciBrunch's preclinical KRAS G12D inhibitor for $2.13B, raising tech transfer and scale-up questions for oral cancer drug development.
Ronald Piervincenzi, USP, urges drugmakers and purchasers to act on supply chain resilience to curb drug shortages and shape better policy.
Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Trending on Pharmaceutical Technology
1
Tavapadon Sets Development Benchmark for Parkinson's
2
KRAS G12D Inhibitor's $2.13B Deal Tests Cross-Border Tech Transfer
3
Weekly Basal Insulin Efsitora: A New Biologics CMC Benchmark
4
PharmTech’s Weekly Roundup—September 25, 2026
5